Dong Ma
Direktor/Vorstandsmitglied bei Zhejiang Taimei Medical Technology Co., Ltd.
Profil
Dong Ma is currently the Executive Director and President-Digital R&D at Zhejiang Taimei Medical Technology Co., Ltd.
He started this position in 2023.
Prior to his current role, Mr. Ma obtained an MBA from the University of Hong Kong in 2020.
He also completed his undergraduate degree at Fudan University in 2006 and a graduate degree at Shanghai Institute of Pharmaceutical Industry in 2009.
Aktive Positionen von Dong Ma
| Unternehmen | Position | Beginn |
|---|---|---|
Zhejiang Taimei Medical Technology Co., Ltd.
 Zhejiang Taimei Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The firm produces products for clinical research, pharmacovigilance and other fields including MobileMD-EDC system and CTMS clinical trial management system. Its product TMCloud, a platform for pharmaceutical enterprises, research and development service companies, research institutions, patients and regulatory agencies. The company was founded by Liang Xiao and Lu Zhao on June 6, 2013 and is headquartered in Jiaxing, China. | Direktor/Vorstandsmitglied | 20.07.2017 |
Ausbildung von Dong Ma
| Fudan University | Undergraduate Degree |
| Shanghai Institute of Pharmaceutical Industry | Graduate Degree |
| University of Hong Kong | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Zhejiang Taimei Medical Technology Co., Ltd. operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance. The firm produces products for clinical research, pharmacovigilance and other fields including MobileMD-EDC system and CTMS clinical trial management system. Its product TMCloud, a platform for pharmaceutical enterprises, research and development service companies, research institutions, patients and regulatory agencies. The company was founded by Liang Xiao and Lu Zhao on June 6, 2013 and is headquartered in Jiaxing, China. | Technology Services |
